Hogenhuis Wladimir 4
4 · Ultragenyx Pharmaceutical Inc. · Filed Oct 7, 2019
Insider Transaction Report
Form 4
Hogenhuis Wladimir
Chief Operating Officer
Transactions
- Tax Payment
Common Stock
2019-10-04$44.52/sh−1,297$57,742→ 18,703 total
Footnotes (2)
- [F1]Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.
- [F2]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.